• 2 ASX 200 shares to watch on Tuesday

    trading, market, ASX, shares, investing

    ASX 200 shares had a strong start to the week as the S&P/ASX 200 Index (ASX: XJO) jumped 1.10% higher on Monday.

    The Resources sector led the benchmark index higher yesterday thanks to strong commodity prices. However, there were more mixed performances across other industries as the market volatility continued.

    Find out which ASX 200 shares I’m watching during today’s trade.

    2 ASX 200 shares to watch on Tuesday

    The BHP Group Ltd (ASX: BHP) share price is one I’m keeping my eye on today. Shares in the Aussie miner jumped 3.09% on Monday thanks to strong iron ore prices, although it has opened today down by 1.68%.

    At the time of writing, BHP is worth a whopping $169.1 billion and is the largest ASX 200 share by market capitalisation right now.

    Investors could continue to back the Aussie miner in 2020, but I still think its a speculative buy right now with so much uncertainty around trade.

    However, there are some tailwinds in the market right now which could push the BHP share price higher. Momentum could be a big factor and I think BHP is one ASX 200 share worth watching today.

    Other than BHP, Wesfarmers Ltd (ASX: WES) could be moving. Wesfarmers is an interesting business in a unique position right now.

    The Aussie conglomerate is sitting on a pile of cash after selling part of its stake in Coles Group Ltd (ASX: COL) for $1.1 billion. However, it’s not all good news for the ASX 200 share right now.

    The group is currently restructuring its retail arm, Kmart Group. In fact, Wesfarmers recently announced the closure of 75 Target stores as sales continue to slump.

    Despite opening slightly down this morning, the Wesfarmers share price has still climbed nearly 8% higher this year and is worth keeping on a watchlist. A strong balance sheet is a big plus and provides flexibility to buy more portfolio companies if the right opportunity arises.

    Foolish takeaway

    There are always many ASX 200 shares worth watching. These are just a couple of the large-caps that I’m keeping an eye during another big day of trade.

    Here are 5 more ASX shares that are worth watching in 2020.

    NEW. The Motley Fool AU Releases Five Cheap and Good Stocks to Buy for 2020 and beyond!….

    Our experts here at The Motley Fool Australia have just released a fantastic report, detailing 5 dirt cheap shares that you can buy in 2020.

    One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

    Another is a diversified conglomerate trading over 40% off its high, all while offering a fully franked dividend yield over 3%…

    Plus 3 more cheap bets that could position you to profit over the next 12 months!

    See for yourself now. Simply click here or the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.

    CLICK HERE FOR YOUR FREE REPORT!

    More reading

    Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of COLESGROUP DEF SET and Wesfarmers Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 2 ASX 200 shares to watch on Tuesday appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/36RsALU

  • 3 ASX shares to buy and hold for the next 2 decades

    man and woman thinking with picture of lightbulbs

    There aren’t too many ASX shares that I’d feel comfortable about buying and committing to owning for two decades.

    But there are a few that I think could be solid ultra-long-term picks. They have shown their worth in the coronavirus so far. 

    Washington H. Soul Pattinson and Co. Ltd (ASX: SOL)

    Soul Patts could be one of the best ASX shares to invest for the long-term in. Only an exchange-traded fund (ETF) may have a better claim.

    It has already been listed on the ASX for over a century, so it clearly has great longevity. But I don’t think it’s on the cusp of irrelevance at all. It’s an investment conglomerate so it can change its investment holdings as time goes on. Soul Patts is apparently about to start investing in regional data centres, a big growth area right now. Current large investments include telecommunications, building products and resources. 

    Of the current shares in the ASX 200, I think Soul Patts could be among the group that will operate for the longest time into the future.

    The management team of Soul Patts themselves invest for the long-term within the company. So it has long-term characteristics. It is steadily increasing its dividend, which is another attractive future.

    Xero Limited (ASX: XRO)

    There are only two things certain in life (as the saying goes). Death and taxes. You can’t do a business tax return without tracking your income, expenses, assets and liabilities, then making financial statements. So why wouldn’t you want to use the best tools available?

    Xero is an ASX share that provides cloud accounting software and it’s resonating with clients across the world.

    It’s no surprise that Xero has a strong market share in New Zealand and Australia as it’s a local business with a great service. But it’s also growing at an extraordinary rate in the UK and doing well in other areas of the world.

    Xero generates attractive monthly cashflow at a very high gross profit margin. At the moment Xero is investing heavily for growth and it’s paying off. In two decades (or just one) it could be one of two clear market leader providers in the world.

    Wesfarmers Ltd (ASX: WES)

    Wesfarmers isn’t normally an ASX share I’d suggest is one of the best dividend shares, or one of the best growth shares. But I think it’s a great blue chip.

    It isn’t stuck being a bank or a miner. It will happily adjust what operating businesses it owns over time. Remember that it acquired and years later divested Coles Group Limited (ASX: COL). Wesfarmers isn’t afraid to make big, bold moves. Even if they don’t work out – look what happened to Bunnings UK and Ireland.

    The point is that Wesfarmers can acquire businesses to position it for future success. For example, it recently acquired a lithium miner and it also acquired online retailer Catch Group.

    Of course, its current businesses are also fantastic. Bunnings may be the best retail businesses in the country.

    Foolish takeaway

    I think all of these ASX shares would make very good ultra-long-term investments at the current prices. Xero may be able to generate the most growth if it keeps adding subscribers, but I prefer Soul Patts for its diversification.

    These three shares aren’t the only shares I’d consider for the next two decades. I’d also want to think about these leading shares…

    NEW. The Motley Fool AU Releases Five Cheap and Good Stocks to Buy for 2020 and beyond!….

    Our experts here at The Motley Fool Australia have just released a fantastic report, detailing 5 dirt cheap shares that you can buy in 2020.

    One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

    Another is a diversified conglomerate trading over 40% off its high, all while offering a fully franked dividend yield over 3%…

    Plus 3 more cheap bets that could position you to profit over the next 12 months!

    See for yourself now. Simply click here or the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.

    CLICK HERE FOR YOUR FREE REPORT!

    More reading

    The post 3 ASX shares to buy and hold for the next 2 decades appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2U2BLUC

  • Eli Lilly CEO Talks Coronavirus Treatment Progress: ‘This Is An Important Bridge Therapy’

    Eli Lilly CEO Talks Coronavirus Treatment Progress: 'This Is An Important Bridge Therapy'Drugmaker Eli Lilly And Co (NYSE: LLY) started a human study of a potential antibody treatment for COVID-19 patients, and CEO David Ricks said on Fox Business that it is the first of its kind.Lilly's Brand New Medicine Eli Lilly's medicine to treat COVID-19 patients is the first of its kind, as it consists of antibodies found in a recovered patient's cells. In contrast, other drugs and therapies are merely "repurposed" from other uses, Ricks said.Eli Lilly scientists collaborated with Canada-based AbCellera to engineer a treatment out of the "very best one or two" antibodies it can find out of millions of cells, the CEO said. The initial study will consist of less than 40 patients, and results are expected in a "couple of weeks," he said. Lilly's Production Timeline Eli Lilly has already started the process of ramping up production for its hopeful therapy despite it being in the early stages of testing, Ricks said.The company expects to produce 100,000 or more doses that will be available in the fall, the CEO said.During the pandemic's peak, there were around 60,000 people in a hospital in the U.S., so 100,000 could treat every person, he said.Important Treatment Before Vaccine Eli Lilly wants to study how its medicine can be used to treat people to avoid the need of going to a hospital in the first place as part of an ambulatory treatment study.The company also wants to explore later on in the summer months how its treatment can be used among those most at risk and vulnerable."This is an important bridge therapy until a vaccination could arrive and even perhaps vaccination this kind of therapy could find an important use," the CEO said.Lilly shares were trading down slightly at $152.86 at the time of publication Monday.Related Links:Moderna Doses First Participants In Phase 2 Study Of Coronavirus Vaccine53% Of Americans 'Very Likely' To Get Coronavirus Vaccine, Rasmussen ReportsEli Lilly CEO David Ricks. Benzinga file photo by Dustin Blitchok. See more from Benzinga * Making Sense Of Why Consumers Are Switching Their Grocery Store Habits * Intermediate Options Strategy With Ally Invest's Brian Overby * Impossible Foods Scores Big Win In Legal Battle With Nestle(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

    from Yahoo Finance https://ift.tt/3eGhY5i